Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis
- 14 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (3) , 318-330
Abstract
Liver transplantation (LT) is a life‐saving treatment for patients with acute liver failure (ALF). Currently, there are few detailed data regarding long‐term outcomes after LT for ALF. We combined prospective data from the Acute Liver Failure Study Group (ALFSG) Registry with those of the Scientific Registry of Transplant Recipients (SRTR) to assess outcomes among consecutive patients with ALF listed for LT. Cohort analysis of detailed pretransplantation data for patients listed for LT for ALF in the ALFSG Registry between January 1998 and October 2018 matched with transplantation‐related data from the SRTR. Primary outcomes were 1‐ and 3‐year post‐LT patient survival. Secondary outcome was receipt of LT; independent associations with successful receipt of LT were determined using multivariable logistic regression. Of 624 patients with ALF listed for LT, 398 (64%) underwent LT, 100 (16%) died without LT, and 126 (20%) recovered spontaneously. Among LT recipients, etiologies included seronegative/indeterminate (22%), drug‐induced liver injury (18%), acetaminophen overdose (APAP; 16%), and viral hepatitis (15%). The 1‐ and 3‐year post‐LT patient survival rates were 91% and 90%, respectively. Comparing those dying on the waiting list versus with those who received LT, the former had more severe multiorgan failure, reflected by increased vasopressor use (65% vs. 22%), mechanical ventilation (84% vs. 57%), and renal replacement therapy (57% vs. 30%; p < 0.0001 for all). After adjusting for relevant covariates, age (adjusted odds ratio [aOR] 1.02, 95% confidence interval [CI] 1.00–1.04), APAP etiology (aOR 2.72, 95% CI 1.42–5.23), requirement for vasopressors (aOR 4.19, 95% CI 2.44–7.20), Grade III/IV hepatic encephalopathy (aOR 2.47, 95% CI 1.29–4.72), and Model for End‐Stage Liver Disease (MELD) scores (aOR 1.05, 95% CI 1.02–1.09; p < 0.05 for all) were independently associated with death without receipt of LT. Post‐LT outcomes for ALF are excellent in this cohort of very ill patients. The development of multiorgan failure while on the transplantation list and APAP ALF etiology were associated with a lower likelihood of successful receipt of LT.Keywords
This publication has 27 references indexed in Scilit:
- Live Donor Liver Transplantation: A Valid Alternative for Critically Ill Patients Suffering From Acute Liver FailureAmerican Journal of Transplantation, 2015
- Two‐year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre studyLiver International, 2014
- Lung Injury and Its Prognostic Significance in Acute Liver FailureCritical Care Medicine, 2014
- Acute Liver FailureNew England Journal of Medicine, 2013
- Lessons from look-back in acute liver failure? A single centre experience of 3300 patientsJournal of Hepatology, 2013
- Liver transplantation for acute liver failure in Europe: Outcomes over 20years from the ELTR databaseJournal of Hepatology, 2012
- Outcomes after living donor liver transplantation for acute liver failure in Japan: Results of a nationwide surveyLiver Transplantation, 2012
- Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control studyLiver International, 2010
- Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study GroupCritical Care Medicine, 2007
- Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United StatesAnnals of Internal Medicine, 2002